BDBM802079 (1R,2S,5S)-N-[1-(cyclopropylmethyl)-3-(methylamino)-2,3-dioxo-propyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide::US20260109672, Example 2

SMILES CNC(=O)C(=O)C(CC1CC1)NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C)C2(C)C

InChI Key InChIKey=DLUPHGAQWWFBOH-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 802079   

TargetReplicase polyprotein 1a(2019-nCoV)
Nxera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 802079BDBM802079((1R,2S,5S)-N-[1-(cyclopropylmethyl)-3-(methylamino...)
Affinity DataKi:  20nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent